Perepu Covid-19 HBPM dose preventive vs intermédiaire JTH


Smadja Covid-19 Hémopathie vasculaire systémique Angiogenesis


VITT & vaccin anti-Covid19 Consensus d'experts


Rivera-Caravaca AOD & Covid-19 TR


EP chez le patient Covid-19


Taquet TV cérébrales & portales Covid-19 vs post vaccination MedRxiv


Pottegard Evènements veineux artériels hémorragiques post vaccination AZ Danemark Norvège BMJ


Lopes Covid-19 & DD élevés anticoagulation curative vs préventive Lancet


Bikdeli B TV cérébrale & COVID-19 population US JACC


ISTH VITT diagnostic clinique & biologique


INSPIRATION Covid-19 prévention MTEV standard vs intermédiaire TR


Vaccin Covid-19 & thrombose. Opinions d'experts.TH


VITT Ontario COVID-19 Science Advisory Table


GHFT Utilisation argatroban VITT


See vaccination Covid-19 & TV cérébrales série US JAMA


Recos VITT - SFNV, SFMV GFHT, GIHP, SFAR, ANARLF, SFNR


Gendron N LA+ & MTEV Covid-19 Arthrit Rheum


ISTH VITT Algorithme Diagnostic & Thérapeutique


ISTH VITT Guidelines


Smadja D MTEV & ATE post vaccination Covid-19 données Vigibase Eur Resp J


Scully M FP4-dependent syndrome post vaccination NEJM


Thaler J VIPIT traitement case report JTH


Greinacher Thrombose thrombocytopénique post vaccination NEJM


EHP Guidance Thrombose & thrombocytopénie post vaccination BSH


Roubinian NH MTEV patients Covid non hospitalisés JAMA lettre

1 sur 4


Etiquette : 
COVID19 - MTEV